Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and moflomycin

daunorubicin has been researched along with moflomycin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auclair, C; Florent, JC; Guillosson, JJ; Monneret, C; Nafziger, J1
Florent, JC; Genot, A; Monneret, C1
Andrivon, W; Callais, F; Guillosson, JJ; Monneret, C; Nafziger, J1
Andrivon, W; Auclair, C; Florent, JC; Guillosson, JJ; Monneret, C; Nafziger, J; Saucier, JM1
Andrivon, W; Florent, JC; Guillosson, JJ; Monneret, C; Nafziger, J1

Other Studies

5 other study(ies) available for daunorubicin and moflomycin

ArticleYear
Pharmacological and physicochemical properties of a new anthracycline with potent antileukemic activity.
    Leukemia research, 1991, Volume: 15, Issue:8

    Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; DNA Topoisomerases, Type II; G2 Phase; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Myeloid; Mice; Mitosis; Oxidation-Reduction

1991
Synthesis and antitumor activity of new anthracyclines.
    The Journal of antibiotics, 1989, Volume: 42, Issue:12

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Daunorubicin; Drug Evaluation, Preclinical; Leukemia L1210; Mice; Tumor Cells, Cultured

1989
A new anthracycline with potent antileukemic activity exhibits reduced mutagenicity.
    Mutation research, 1995, Volume: 344, Issue:3-4

    Topics: Antibiotics, Antineoplastic; Biotransformation; Daunorubicin; Doxorubicin; Leukemia; Mutagenicity Tests; Mutagens; Salmonella typhimurium

1995
Enhanced topoisomerase II-induced DNA breaks and free radical production by a new anthracycline with potent antileukemic activity.
    Leukemia research, 1996, Volume: 20, Issue:2

    Topics: Antibiotics, Antineoplastic; Daunorubicin; DNA; DNA Damage; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Free Radicals; Humans; Leukemia; Reactive Oxygen Species; Structure-Activity Relationship; Topoisomerase II Inhibitors

1996
A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistance.
    Leukemia research, 1998, Volume: 22, Issue:8

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; HL-60 Cells; Humans; Tumor Cells, Cultured; Verapamil

1998